CRDF – cardiff oncology, inc. (US:NASDAQ)
Stock Stats
News
Cardiff Oncology, Inc. (NASDAQ: CRDF) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
Cardiff Oncology First Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Cardiff Oncology, Inc. (NASDAQ:CRDF) Q1 2023 Earnings Call Transcript [Yahoo! Finance]
Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update [Yahoo! Finance]
Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update
Form 8-K Cardiff Oncology, Inc. For: May 02
Form 10-Q Cardiff Oncology, Inc. For: Mar 31
Form DEFA14A Cardiff Oncology, Inc.
Form ARS Cardiff Oncology, Inc. For: Dec 31
Form DEF 14A Cardiff Oncology, Inc. For: Jun 20
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.